Clinical Trial Update: Using A Novel Classification System in Intravenous GCs Therapy of TAO: A Multi-central, Randomized, Open, Superior Trial [Phase 4]

View source ↗

Summary

This is a Phase 4 multicenter randomized trial evaluating a novel classification system in intravenous glucocorticoid therapy for Thyroid-associated ophthalmopa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid-associated Ophthalmopathy

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Jie Shen | Conditions: Thyroid Associated Ophthalmopathy | Phase 4 | Status: UNKNOWN